drugset / Trial / NCT02289079

TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy

NCT02289079 ↗

Phase 4 Completed 60 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to compare pain control after robotic hysterectomy surgery using either liposomal bupivacaine or Bupivacaine when injected during a transversus abdominis plane (TAP) block. Robotic hysterectomy is when a patient is electively having robotic assisted removal of one's uterus. Both medications liposomal bupivacaine and Bupivacaine are standard of care in these types of surgeries.

Timeline

Start
2013-06
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % —
Subject Bupivacaine Other / unclassified 30 ml —

Indications

No indication recorded.